Cargando…
Endogenous Kynurenine Aminotransferases Inhibitor is Proposed to Act as “Glia Depressing Factor” (GDF)
The endogenous neuroinhibitory amino acid receptor antagonist kynurenic acid (KYNA) has been hypothetically linked to physiological processes and to the pathogenesis of several brain disorders. The aim of this study was to search KYNA metabolism i.e. KYNA levels and enzymes synthesising KYNA kynuren...
Autores principales: | Baran, Halina, Kepplinger, Berthold, Draxler, Markus |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Libertas Academica
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3195239/ https://www.ncbi.nlm.nih.gov/pubmed/22084585 |
Ejemplares similares
-
Effects of Various Kynurenine Metabolites on Respiratory Parameters of Rat Brain, Liver and Heart Mitochondria
por: Baran, Halina, et al.
Publicado: (2016) -
Kynurenine Aminotransferase Isozyme Inhibitors: A Review
por: Nematollahi, Alireza, et al.
Publicado: (2016) -
Improvement of kynurenine aminotransferase-II inhibitors guided by mimicking sulfate esters
por: Jayawickrama, Gayan S., et al.
Publicado: (2018) -
Heterocyclic Cathinones as Inhibitors of Kynurenine Aminotransferase II—Design, Synthesis, and Evaluation
por: Maryška, Michal, et al.
Publicado: (2021) -
Characteristic Features of Kynurenine Aminotransferase Allosterically Regulated by (Alpha)-Ketoglutarate in Cooperation with Kynurenine
por: Okada, Ken, et al.
Publicado: (2012)